Drug Discovery Prospect from Untapped Species: Indications from Approved Natural Product Drugs

Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting

(2011) F. Zhu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Approaches to Capturing and Designing Biologically Active Small Molecules Produced by Uncultured Microbes

(2010) Jörn Piel   Annual Review of Microbiology

Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms

(2010) Yi-Ming Chiang et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine

(2009) Hirofumi Nakano et al.   JOURNAL OF ANTIBIOTICS

Tubulin-Interactive Natural Products as Anticancer Agents(1)

(2009) David G. I. Kingston   JOURNAL OF NATURAL PRODUCTS

Discovery of Ixabepilone

(2009) J. T. Hunt   MOLECULAR CANCER THERAPEUTICS

Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans

(2009) V. Schroeckh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Drug Discovery and Natural Products: End of an Era or an Endless Frontier?

(2009) J. W.-H. Li et al.   SCIENCE

Renaissance in antibacterial discovery from actinomycetes

(2008) R BALTZ   CURRENT OPINION IN PHARMACOLOGY

Part I: Milestones in personalised medicine—imatinib

(2008) Carlo Gambacorti-Passerini   LANCET ONCOLOGY

Database resources of the National Center for Biotechnology Information

(2008) E. W. Sayers et al.   NUCLEIC ACIDS RESEARCH